MAPK-activated protein kinases (MKs): Novel insights and challenges

Frontiers in Cell and Developmental Biology

Volumn 3, Issue JAN, 2016, Pages

  Gaestel, Matthias ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Common docking motif; Dendritic cells; DMBA induced skin tumors; ERK3 4; Macrophage specific activation; Mouse gene targeting strategy; P38 MAPK; Ras induced senescence

Indexed keywords

EID: 85042783008     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2015.00088     Document Type: Short Survey

References (36)

1. Aberg, E., Perander, M., Johansen, B., Julien, C., Meloche, S., Keyse, S. M., et al. (2006). Regulation of MAPK-activated protein kinase 5 activity and subcellular localization by the atypical MAPK ERK4/MAPK4. J. Biol. Chem. 281, 35499-35510. doi: 10.1074/jbc.M606225200
2. Aberg, E., Torgersen, K. M., Johansen, B., Keyse, S. M., Perander, M., and Seternes, O.-M. (2009). Docking of PRAK/MK5 to the atypical MAPKs ERK3 and ERK4 defines a novel MAPK interaction motif. J. Biol. Chem. 284, 19392-19401. doi: 10.1074/jbc.M109.023283
3. Alexa, A., Gógl, G., Glatz, G., Garai, á., Zeke, A., Varga, J., et al. (2015). Structural assembly of the signaling competent ERK2-RSK1 heterodimeric protein kinase complex. Proc. Natl. Acad. Sci. U.S.A. 112, 2711-2716. doi: 10.1073/pnas.1417571112
4. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., et al. (2007). The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315. doi: 10.1042/BJ20070797
5. Cargnello, M., and Roux, P. P. (2011). Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75, 50-83. doi: 10.1128/MMBR.00031-10
6. Chow, K. T., Timblin, G. A., McWhirter, S. M., and Schlissel, M. S. (2013). MK5 activates Rag transcription via Foxo1 in developing B cells. J. Exp. Med. 210, 1621-1634. doi: 10.1084/jem.20130498
7. De la Mota-Peynado, A., Chernoff, J., and Beeser, A. (2011). Identification of the atypical MAPK Erk3 as a novel substrate for p21-activated kinase (Pak) activity. J. Biol. Chem. 286, 13603-13611. doi: 10.1074/jbc.M110.181743
8. Déléris, P., Trost, M., Topisirovic, I., Tanguay, P.-L., Borden, K. L. B., Thibault, P., et al. (2011). Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway. J. Biol. Chem. 286, 6470-6478. doi: 10.1074/jbc.M110.181529
9. Gaestel, M. (2006). MAPKAP kinases-MKs-two's company, three's a crowd. Nat. Rev. Mol. Cell Biol. 7, 120-130. doi: 10.1038/nrm1834
10. Gaestel, M. (2008). Specificity of signaling from MAPKs to MAPKAPKs: kinases' tango nuevo. Front. Biosci. 13, 6050-6059. doi: 10.2741/3136
11. Garai, á., Zeke, A., Gógl, G., Töro, I., Fördos, F., Blankenburg, H., et al. (2012). Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove. Sci. Signal. 5, ra74. doi: 10.1126/scisignal.2003004
12. Heidenreich, O., Neininger, A., Schratt, G., Zinck, R., Cahill, M. A., Engel, K., et al. (1999). MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J. Biol. Chem. 274, 14434-14443
13. Jain, R., Mathur, M., Lan, J., Costales, A., Atallah, G., Ramurthy, S., et al. (2015). Discovery of potent and selective rsk inhibitors as biological probes. J. Med. Chem. 58, 6766-6783. doi: 10.1021/acs.jmedchem.5b00450
14. Kobayashi, M., Nishita, M., Mishima, T., Ohashi, K., and Mizuno, K. (2006). MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration. EMBO J. 25, 713-726. doi: 10.1038/sj.emboj.7600973
15. Kostenko, S., Johannessen, M., and Moens, U. (2009). PKA-induced F-actin rearrangement requires phosphorylation of Hsp27 by the MAPKAP kinase MK5. Cell. Signal. 21, 712-718. doi: 10.1016/j.cellsig.2009.01.009
16. Kotlyarov, A., Yannoni, Y., Fritz, S., Laass, K., Telliez, J.-B., Pitman, D., et al. (2002). Distinct cellular functions of MK2. Mol. Cell Biol. 22, 4827-4835. doi: 10.1128/MCB.22.13.4827-4835.2002
17. Kress, T. R., Cannell, I. G., Brenkman, A. B., Samans, B., Gaestel, M., Roepman, P., et al. (2011). The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. Mol. Cell 41, 445-457. doi: 10.1016/j.molcel.2011.01.023
18. Ludwig, S., Engel, K., Hoffmeyer, A., Sithanandam, G., Neufeld, B., Palm, D., et al. (1996). 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol. Cell Biol. 16, 6687-6697
19. Lukas, S. M., Kroe, R. R., Wildeson, J., Peet, G. W., Frego, L., Davidson, W., et al. (2004). Catalysis and function of the p38 alpha. MK2a signaling complex. Biochemistry 43, 9950-9960. doi: 10.1021/bi049508v
20. Menon, M. B., Schwermann, J., Singh, A. K., Franz-Wachtel, M., Pabst, O., Seidler, U., et al. (2010). p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins. J. Biol. Chem. 285, 33242-33251. doi: 10.1074/jbc.M110.132357
21. New, L., Jiang, Y., and Han, J. (2003). Regulation of PRAK subcellular location by p38 MAP kinases. Mol. Biol. Cell 14, 2603-2616. doi: 10.1091/mbc.E02-08-0538
22. New, L., Jiang, Y., Zhao, M., Liu, K., Zhu, W., Flood, L. J., et al. (1998). PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J. 17, 3372-3384. doi: 10.1093/emboj/17.12.3372
23. Ni, H., Wang, X. S., Diener, K., and Yao, Z. (1998). MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase. Biochem. Biophys. Res. Commun. 243, 492-496. doi: 10.1006/bbrc.1998.8135
24. Roffé, M., Lupinacci, F. C., Soares, L. C., Hajj, G. N., and Martins, V. R. (2015). Cellular signalling. Cell. Signal. 27, 1630-1642. doi: 10.1016/j.cellsig.2015.04.004
25. Ronkina, N., Johansen, C., Bohlmann, L., Lafera, J., Menon, M. B., Tiedje, C., et al. (2015). Comparative analysis of two gene-targeting approaches challenges the tumor-suppressive role of the protein kinase MK5/PRAK. PLoS ONE 10:e0136138. doi: 10.1371/journal.pone.0136138.s006
26. Ronkina, N., Menon, M. B., Schwermann, J., Arthur, J. S. C., Legault, H., Telliez, J.-B., et al. (2011). Stress induced gene expression: a direct role for MAPKAP kinases in transcriptional activation of immediate early genes. Nucleic Acids Res. 39, 2503-2518. doi: 10.1093/nar/gkq1178
27. Shi, Y., Kotlyarov, A., Laabeta, K., Gruber, A. D., Butt, E., Marcus, K., et al. (2003). Elimination of protein kinase MK5/PRAK activity by targeted homologous recombination. Mol. Cell Biol. 23, 7732-7741. doi: 10.1128/MCB.23.21.7732-7741.2003
28. Sudo, T., Kawai, K., Matsuzaki, H., and Osada, H. (2005). p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression. Biochem. Biophys. Res. Commun. 337, 415-421. doi: 10.1016/j.bbrc.2005.09.063
29. Sun, P., Yoshizuka, N., New, L., Moser, B. A., Li, Y., Liao, R., et al. (2007). PRAK is essential for ras-induced senescence and tumor suppression. Cell 128, 295-308. doi: 10.1016/j.cell.2006.11.050
30. Tanoue, T., Adachi, M., Moriguchi, T., and Nishida, E. (2000). A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell Biol. 2, 110-116. doi: 10.1038/35000065
31. White, A., Pargellis, C. A., Studts, J. M., Werneburg, B. G., and Farmer, B. T. (2007). Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc. Natl. Acad. Sci. U.S.A. 104, 6353-6358. doi: 10.1073/pnas.0701679104
32. Yoshizuka, N., Chen, R. M., Xu, Z., Liao, R., Hong, L., Hu, W.-Y., et al. (2012). A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis. Mol. Cell Biol. 32, 606-618. doi: 10.1128/MCB.06301-11
33. Zaru, R., Edgar, A. J., Hanauer, A., and Watts, C. (2014). Structural and functional basis for p38-MK2-activated Rsk signaling in toll-like receptor-stimulated dendritic cells. Mol. Cell Biol. 35, 132-140. doi: 10.1128/MCB.00773-14
34. Zaru, R., Ronkina, N., Gaestel, M., Arthur, J. S. C., and Watts, C. (2007). The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat. Immunol. 8, 1227-1235. doi: 10.1038/ni1517
35. Zheng, H., Seit-Nebi, A., Han, X., Aslanian, A., Tat, J., Liao, R., et al. (2013). A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence. Mol. Cell 50, 699-710. doi: 10.1016/j.molcel.2013.04.013
36. Zheng, M., Wang, Y.-H., Wu, X.-N., Wu, S.-Q., Lu, B.-J., Dong, M.-Q., et al. (2011). Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1. Nat. Cell Biol. 13, 263-272. doi: 10.1038/ncb2168